BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 20094044)

  • 1. Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis.
    Reid BJ; Li X; Galipeau PC; Vaughan TL
    Nat Rev Cancer; 2010 Feb; 10(2):87-101. PubMed ID: 20094044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barrett's oesophagus: frequency and prediction of dysplasia and cancer.
    Falk GW
    Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):125-38. PubMed ID: 25743461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprevention in Barrett's oesophagus.
    Baruah A; Buttar NS
    Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):151-65. PubMed ID: 25743463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant Barrett's oesophagus.
    Li H
    Eur J Cancer Prev; 1993 Jan; 2(1):47-52. PubMed ID: 8428176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota.
    Conio M; Cameron AJ; Romero Y; Branch CD; Schleck CD; Burgart LJ; Zinsmeister AR; Melton LJ; Locke GR
    Gut; 2001 Mar; 48(3):304-9. PubMed ID: 11171817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barrett's oesophagus: Current controversies.
    Amadi C; Gatenby P
    World J Gastroenterol; 2017 Jul; 23(28):5051-5067. PubMed ID: 28811703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Revision needed of follow-up policy for Barrett's esophagus].
    Giard RW; Coebergh JW; Ouwendijk RJ
    Ned Tijdschr Geneeskd; 2002 Jan; 146(4):150-4. PubMed ID: 11845562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barrett's oesophagus: epidemiology, cancer risk and implications for management.
    de Jonge PJ; van Blankenstein M; Grady WM; Kuipers EJ
    Gut; 2014 Jan; 63(1):191-202. PubMed ID: 24092861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of p53 in Barrett's oesophagus.
    Krishnadath KK; van Blankenstein M; Tilanus HW
    Eur J Gastroenterol Hepatol; 1995 Jan; 7(1):81-4. PubMed ID: 7866817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary factors and the risks of oesophageal adenocarcinoma and Barrett's oesophagus.
    Kubo A; Corley DA; Jensen CD; Kaur R
    Nutr Res Rev; 2010 Dec; 23(2):230-46. PubMed ID: 20624335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the epidemiology of Barrett's oesophagus and oesophageal adenocarcinoma.
    Schneider JL; Corley DA
    Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):29-39. PubMed ID: 25743454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ablation of Barrett's oesophagus: towards improved outcomes for oesophageal cancer?
    Mayne GC; Bright T; Hussey DJ; Watson DI
    ANZ J Surg; 2012 Sep; 82(9):592-8. PubMed ID: 22901306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case-control study in US male veterans.
    Tan MC; El-Serag HB; Yu X; Thrift AP
    Aliment Pharmacol Ther; 2018 Aug; 48(4):469-477. PubMed ID: 29956826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased detection rates of Barrett's oesophagus without rise in incidence of oesophageal adenocarcinoma.
    Hurschler D; Borovicka J; Neuweiler J; Oehlschlegel C; Sagmeister M; Meyenberger C; Schmid U
    Swiss Med Wkly; 2003 Sep; 133(37-38):507-14. PubMed ID: 14652799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single centre's 20 years' experience of columnar-lined (Barrett's) oesophagus diagnosis.
    Caygill CP; Reed PI; Johnston BJ; Hill MJ; Ali MH; Levi S
    Eur J Gastroenterol Hepatol; 1999 Dec; 11(12):1355-8. PubMed ID: 10654794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and populations at risk: selection of patients for screening for Barrett's oesophagus.
    Rubenstein JH; Thrift AP
    Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):41-50. PubMed ID: 25743455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux.
    Solaymani-Dodaran M; Logan RF; West J; Card T; Coupland C
    Gut; 2004 Aug; 53(8):1070-4. PubMed ID: 15247170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daily use of non-steroidal anti-inflammatory drugs is less frequent in patients with Barrett's oesophagus who develop an oesophageal adenocarcinoma.
    Tsibouris P; Hendrickse MT; Isaacs PE
    Aliment Pharmacol Ther; 2004 Sep; 20(6):645-55. PubMed ID: 15352913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Length of Barrett's oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma.
    Pohl H; Pech O; Arash H; Stolte M; Manner H; May A; Kraywinkel K; Sonnenberg A; Ell C
    Gut; 2016 Feb; 65(2):196-201. PubMed ID: 26113177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenocarcinoma and Barrett's oesophagus. A clinico-pathological study.
    Moghissi K; Sharpe DA; Pender D
    Eur J Cardiothorac Surg; 1993; 7(3):126-31. PubMed ID: 8461144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.